VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Vaccine Mechanisms
Vaximmutordb
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From
Warning: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /data/var/www/html/violinet/litesearch/vaxlert/content.php on line 45

Warning: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /data/var/www/html/violinet/litesearch/vaxlert/content.php on line 45

Warning: mktime(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /data/var/www/html/violinet/litesearch/vaxlert/content.php on line 45

Warning: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /data/var/www/html/violinet/litesearch/vaxlert/content.php on line 45
Aug 01, 2018 To
Warning: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /data/var/www/html/violinet/litesearch/vaxlert/content.php on line 45
Aug 17, 2018:


Bacillus anthracis (Anthrax)

  1. Fasanella A, Serrecchia L, Chiaverini A, Garofolo G, Muuka GM, Mwambazi L. Use of Canonical Single Nucleotide Polymorphism (CanSNPs) to characterize <i>Bacillus anthracis</i> outbreak strains in Zambia between 1990 and 2014 PeerJ 6:e5270 2018 [PMID: 30065876]

Brucella (Brucellosis)

  1. Higgins JL, Bowen RA, Gonzalez-Juarrero M. Cell mediated immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence strain Rev. 1 Veterinary immunology and immunopathology 202:74-84 2018 [PMID: 30078602]
  2. Kim WK, Moon JY, Cho JS, Park BY, Hur J. Protective efficacy of a canine brucellosis vaccine candidate based on live attenuated Salmonella expressing recombinant Brucella BSCP31, Omp3b and SOD proteins in Beagles The Journal of veterinary medical science 2018 [PMID: 30068897]
  3. Hull NC, Schumaker BA. Comparisons of brucellosis between human and veterinary medicine Infection ecology & epidemiology 8(1):1500846 2018 [PMID: 30083304]

Chlamydia psittaci (Psittacosis)

  1. Tan Y, Li Y, Zhang Y, Yu J, Wen Y, Wang C, Xu M, Chen Q, Lu C, Wu Y. Immunization with Chlamydia psittaci plasmid-encoded protein CPSIT_p7 induces partial protective immunity against chlamydia lung infection in mice Immunologic research 2018 [PMID: 30097797]
  2. Rademaker M, Agnew K, Anagnostou N, Andrews M, Armour K, Baker C, Foley P, Gebauer K, Gupta M, Marshman G, Rubel D, Sullivan J, Wong LC. Psoriasis and infection. A clinical practice narrative The Australasian journal of dermatology 2018 [PMID: 30079566]

Clostridium botulinum toxin (Botulism)

  1. Silva ROS, Duarte MC, Oliveira Junior CA, de Assis RA, Lana AMQ, Lobato FCF. Comparison of humoral neutralizing antibody response in rabbits, guinea pigs, and cattle vaccinated with epsilon and beta toxoids from Clostridium perfringens and C. botulinum types C and D toxoids Anaerobe 54:19-22 2018 [PMID: 30076896]

Clostridium perfringens

  1. Dicks LMT, Mikkelsen LS, Brandsborg E, Marcotte H. Clostridium difficile, the Difficult "Kloster" Fuelled by Antibiotics Current microbiology 2018 [PMID: 30084095]
  2. Silva ROS, Duarte MC, Oliveira Junior CA, de Assis RA, Lana AMQ, Lobato FCF. Comparison of humoral neutralizing antibody response in rabbits, guinea pigs, and cattle vaccinated with epsilon and beta toxoids from Clostridium perfringens and C. botulinum types C and D toxoids Anaerobe 54:19-22 2018 [PMID: 30076896]

Coxiella burnetii (Q fever)

  1. Lindsay PJ, Rohailla S, Miyakis S. Q Fever in Rural Australia: Education Versus Vaccination Vector borne and zoonotic diseases (Larchmont, N.Y.) 2018 [PMID: 30085903]

Ebola virus

  1. Lu DY, Wu HY, Yarla NS, Lu TR, Xu B, Jian-Ding. Ebola Therapeutic Study and Future Directions Infectious disorders drug targets 2018 [PMID: 30101721]
  2. Bramble MS, Hoff N, Gilchuk P, Mukadi P, Lu K, Doshi RH, Steffen I, Nicholson BP, Lipson A, Vashist N, Sinai C, Spencer D, Olinger G, Wemakoy EO, Illunga BK, Pettitt J, Logue J, Marchand J, Varughese J, Bennett RS, Jahrling P, Cavet G, Serafini T, Ollmann Saphire E, Vilain E, Muyembe-Tamfum JJ, Hensely LE, Simmons G, Crowe JE Jr, Rimoin AW. Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors The Journal of infectious diseases 2018 [PMID: 30107445]
  3. Lévy Y, Lane C, Piot P, Beavogui AH, Kieh M, Leigh B, Doumbia S, D'Ortenzio E, Lévy-Marchal C, Pierson J, Watson-Jones D, Nguyen VK, Larson H, Lysander J, Lacabaratz C, Thiebaut R, Augier A, Ishola D, Kennedy S, Chêne G, Greenwood B, Neaton J, Yazdanpanah Y. Prevention of Ebola virus disease through vaccination: where we are in 2018 Lancet (London, England) 2018 [PMID: 30104048]
  4. Kumar D, Gauthami S, Uma M, Nagalekshmi K, Rao PP, Basu A, Ella KM, Hegde NR. Immunogenicity of a Candidate Ebola Hemorrhagic Fever Vaccine in Mice Based on Controlled In Vitro Expression of Ebolavirus Glycoprotein Viral immunology 2018 [PMID: 30095362]
  5. Saphire EO, Schendel SL, Fusco ML, Gangavarapu K, Gunn BM, Wec AZ, Halfmann PJ, Brannan JM, Herbert AS, Qiu X, Wagh K, He S, Giorgi EE, Theiler J, Pommert KBJ, Krause TB, Turner HL, Murin CD, Pallesen J, Davidson E, Ahmed R, Aman MJ, Bukreyev A, Burton DR, Crowe JE Jr, Davis CW, Georgiou G, Krammer F, Kyratsous CA, Lai JR, Nykiforuk C, Pauly MH, Rijal P, Takada A, Townsend AR, Volchkov V, Walker LM, Wang CI, Zeitlin L, Doranz BJ, Ward AB, Korber B, Kobinger GP, Andersen KG, Kawaoka Y, Alter G, Chandran K, Dye JM. Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection Cell 174(4):938-952.e13 2018 [PMID: 30096313]
  6. Robinson HL, Marzi A. Ebola virus - prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine Expert review of vaccines 2018 [PMID: 30092691]
  7. Gunn BM, Yu WH, Karim MM, Brannan JM, Herbert AS, Wec AZ, Halfmann PJ, Fusco ML, Schendel SL, Gangavarapu K, Krause T, Qiu X, He S, Das J, Suscovich TJ, Lai J, Chandran K, Zeitlin L, Crowe JE Jr, Lauffenburger D, Kawaoka Y, Kobinger GP, Andersen KG, Dye JM, Saphire EO, Alter G. A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus Cell host & microbe 24(2):221-233.e5 2018 [PMID: 30092199]
  8. Moody MA. Strength through Organization: Classifying Antibody Activity against EBOV Cell host & microbe 24(2):185-186 2018 [PMID: 30092192]
  9. Iampietro M, Santos RI, Lubaki NM, Bukreyev A. Ebola Virus Shed Glycoprotein Triggers Differentiation, Infection, and Death of Monocytes Through Toll-Like Receptor 4 Activation The Journal of infectious diseases 2018 [PMID: 30085081]
  10. Bowyer G, Rampling T, Powlson J, Morter R, Wright D, Hill AVS, Ewer KJ. Activation-induced Markers Detect Vaccine-Specific CD4⁺ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials Vaccines 6(3) 2018 [PMID: 30065162]

Escherichia coli

  1. Yates LE, Mills DC, DeLisa MP. Bacterial Glycoengineering as a Biosynthetic Route to Customized Glycomolecules Advances in biochemical engineering/biotechnology 2018 [PMID: 30099598]
  2. Shekar A, Ramlal S, Jeyabalaji JK, Sripathy MH. Intranasal immunization of cocktail/fusion protein containing Tir along with ΔG active fragment of Zot as mucosal adjuvant confers enhanced immunogenicity and reduces E. coli O157:H7 shedding in mice International immunopharmacology 63:211-219 2018 [PMID: 30103196]
  3. Ahn H, Kim J, Kwon S, Kim PH, Kwon HM, Lee E, Lee GS. Triggers of NLRC4 and AIM2 inflammasomes induce porcine IL-1β secretion Veterinary research communications 2018 [PMID: 30097755]
  4. Kuenstling TE, Sambol AR, Hinrichs SH, Larson MA. Oligomerization of bacterially expressed H1N1 recombinant hemagglutinin contributes to protection against viral challenge Scientific reports 8(1):11856 2018 [PMID: 30087372]
  5. Magistro G, Stief CG. Vaccine Development for Urinary Tract Infections: Where Do We Stand? European urology focus 2018 [PMID: 30093359]
  6. Zegeye ED, Govasli ML, Sommerfelt H, Puntervoll P. Development of an enterotoxigenic Escherichia coli vaccine based on the heat-stable toxin Human vaccines & immunotherapeutics 2018 [PMID: 30081709]
  7. Agrawal A, Bisharyan Y, Papoyan A, Bednenko J, Cardarelli J, Yao M, Clark T, Berkmen M, Ke N, Colussi P. Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli Protein expression and purification 2018 [PMID: 30081196]
  8. Nesta B, Pizza M. Vaccines Against Escherichia coli Current topics in microbiology and immunology 2018 [PMID: 30062594]
  9. Thwaite R, Ji J, Torrealba D, Coll J, Sabés M, Villaverde A, Roher N. Protein Nanoparticles Made of Recombinant Viral Antigens: A Promising Biomaterial for Oral Delivery of Fish Prophylactics Frontiers in immunology 9:1652 2018 [PMID: 30072996]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Traore YL, Chen Y, Ho EA. Current State of Microbicide Development Clinical pharmacology and therapeutics 2018 [PMID: 30107032]
  2. Peterson AR, Nash E, Anderson BJ. Infectious Disease in Contact Sports Sports health :1941738118789954 2018 [PMID: 30106670]
  3. Kardava L, Sohn H, Youn C, Austin JW, Wang W, Buckner CM, Justement JS, Melson VA, Roth GE, Hand MA, Gittens KR, Kwan RW, Sneller MC, Li Y, Chun TW, Sun PD, Pierce SK, Moir S. IgG3 regulates tissue-like memory B cells in HIV-infected individuals Nature immunology 2018 [PMID: 30104633]
  4. Perdiguero B, Raman SC, Sánchez-Corzo C, Sorzano COS, Valverde JR, Esteban M, Gómez CE. Potent HIV-1-Specific CD8 T Cell Responses Induced in Mice after Priming with a Multiepitopic DNA-TMEP and Boosting with the HIV Vaccine MVA-B Viruses 10(8) 2018 [PMID: 30104537]
  5. Robinson HL. HIV/AIDS Vaccines: 2018 Clinical pharmacology and therapeutics 2018 [PMID: 30099743]
  6. Fitzgerald FC, Lhomme E, Harris K, Kenny J, Doyle R, Kityo C, Shaw LB, Abongomera G, Musiime V, Cook A, Brown JR, Brooks A, Owen-Powell E, Gibb DM, Prendergast AJ, Walker AS, Thiebaut R, Klein N. Microbial translocation does not drive immune activation in Ugandan children with HIV The Journal of infectious diseases 2018 [PMID: 30107546]
  7. Damjanovic D, He L, Symes J, Gajewska B, Azizi A, Salha D, Ettorre L, Bernardo-Reyes L, Su J, Phogat S, Gisonni-Lex L. In vitro assessment of biological activity and stability of the ALVAC-HIV vaccine Vaccine 2018 [PMID: 30104115]
  8. Suliman S, Luabeya AKK, Geldenhuys H, Tameris M, Hoff ST, Shi Z, Tait D, Kromann I, Ruhwald M, Rutkowski KT, Shepherd B, Hokey D, Ginsberg AM, Hanekom WA, Andersen P, Scriba TJ, Hatherill M. Dose Optimization of H56:IC31 Vaccine for TB Endemic Populations: A Double-Blind, Placebo-Controlled, Dose-Selection Trial American journal of respiratory and critical care medicine 2018 [PMID: 30092143]
  9. Rathore U, Purwar M, Vignesh VS, Das R, Kumar AA, Bhattacharyya S, Arendt HE, DeStefano J, Wilson A, Parks C, LaBranche CC, Montefiori DC, Varadarajan R. Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4 binding site neutralizing antibodies The Journal of biological chemistry 2018 [PMID: 30093409]
  10. Tabler J, Mykyta L, Schmitz RM, Kamimura A, Martinez DA, Martinez RD, Flores P, Gonzalez K, Marquez A, Marroquin G, Torres A. Social Determinants of Sexual Behavior and Awareness of Sexually Transmitted Infections (STI) Among Low-Income HIV+ or STI At-Risk Hispanic Residents Receiving Care at the U.S.-Mexico Border Journal of community health 2018 [PMID: 30094723]
  11. Kahyesh-Esfandiary R, Sadigh ZA, Esghaei M, Bastani MN, Donyavi T, Najafi A, Fakhim A, Bokharaei-Salim F. Detection of HCV Genome in Peripheral Blood Mononuclear Cells of Iranian Seropositive and HCV RNA negative in Plasma of Patients with Beta-thalassemia Major: Occult HCV Infection Journal of medical virology 2018 [PMID: 30091793]
  12. Jin JW, Tang SQ, Rong MZ, Zhang MQ. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses Acta biomaterialia 2018 [PMID: 30098441]
  13. Colin De Verdiere N, Durier C, Samri A, Meiffredy V, Launay O, Matheron S, Mercier-Delarue S, Even S, Aboulker JP, Molina JM, Autran B, Simon F. Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients: ANRS EP46 NOVAA AIDS (London, England) 2018 [PMID: 30096071]
  14. Kroon E, Pham PT, Sirivichayakul S, Trichavaroj R, Colby DJ, Pinyakorn S, Phanuphak N, Sanders-Buell E, Van Griensven F, Kijak GH, Kim JH, Michael NL, Robb ML, Ananworanich J, De Souza MS, Tovanabutra S. Transmission dynamics among participants initiating anti-retroviral therapy upon diagnosis of early acute HIV-1 infection in Thailand AIDS (London, England) 2018 [PMID: 30096068]
  15. Phillips B, Van Rompay KKA, Rodriguez-Nieves J, Lorin C, Koutsoukos M, Tomai M, Fox CB, Eudailey J, Dennis M, Alam SM, Hudgens M, Fouda G, Pollara J, Moody A, Shen X, Ferrari G, Permar S, De Paris K. Adjuvant-dependent enhancement of HIV Env-specific antibody responses in infant rhesus macaques Journal of virology 2018 [PMID: 30089691]
  16. Li W, Balachandran YL, Hao Y, Hao X, Li R, Nan Z, Zhang H, Shao Y, Liu Y. Amantadine Surface-Modified Silver Nanorods Improves Immunotherapy of HIV Vaccine against HIV-Infected Cells ACS applied materials & interfaces 2018 [PMID: 30085647]
  17. Kloning T, Nowotny T, Alberer M, Hoelscher M, Hoffmann A, Froeschl G. Morbidity profile and sociodemographic characteristics of unaccompanied refugee minors seen by paediatric practices between October 2014 and February 2016 in Bavaria, Germany BMC public health 18(1):983 2018 [PMID: 30086731]
  18. Flores GL, Cruz HM, Miguel JC, Potsch DV, Pilotto JH, Lewis-Ximenez LL, Lampe E, Villar LM. Assessing Hepatitis B immunity using dried blood spot samples from HIV<sup>+</sup> individuals Journal of medical virology 2018 [PMID: 30085359]
  19. Herrera BB, Tsai WY, Brites C, Luz E, Pedroso C, Drexler JF, Wang WK, Kanki PJ. T Cell Responses to Nonstructural Protein 3 Distinguish Infections by Dengue and Zika Viruses mBio 9(4) 2018 [PMID: 30087165]
  20. Walters LC, Harlos K, Brackenridge S, Rozbesky D, Barrett JR, Jain V, Walter TS, O'Callaghan CA, Borrow P, Toebes M, Hansen SG, Sacha J, Abdulhaqq S, Greene JM, Früh K, Marshall E, Picker LJ, Jones EY, McMichael AJ, Gillespie GM. Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding Nature communications 9(1):3137 2018 [PMID: 30087334]
  21. Patricia D'Souza M, Allen MA, Baumblatt JAG, Boggiano C, Crotty S, Grady C, Havenar-Daughton C, Heit A, Hu DJ, Kunwar N, McElrath MJ. Innovative approaches to track lymph node germinal center responses to evaluate development of broadly neutralizing antibodies in human HIV vaccine trials Vaccine 2018 [PMID: 30097219]
  22. Schilling KA, Awuor AO, Rajasingham A, Moke F, Omore R, Amollo M, Farag TH, Nasrin D, Nataro JP, Kotloff KL, Levine MM, Ayers T, Laserson K, Blackstock A, Rothenberg R, Stauber CE, Mintz E, Breiman RF, O'Reilly CE. Water, Sanitation, and Hygiene Characteristics among HIV-Positive Households Participating in the Global Enterics Multicenter Study in Rural Western Kenya, 2008-2012 The American journal of tropical medicine and hygiene 2018 [PMID: 30084344]
  23. Okoye AA, Hansen SG, Vaidya M, Fukazawa Y, Park H, Duell DM, Lum R, Hughes CM, Ventura AB, Ainslie E, Ford JC, Morrow D, Gilbride RM, Legasse AW, Hesselgesser J, Geleziunas R, Li Y, Oswald K, Shoemaker R, Fast R, Bosche WJ, Borate BR, Edlefsen PT, Axthelm MK, Picker LJ, Lifson JD. Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound Nature medicine 2018 [PMID: 30082858]
  24. Mokaya J, McNaughton AL, Hadley MJ, Beloukas A, Geretti AM, Goedhals D, Matthews PC. A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action PLoS neglected tropical diseases 12(8):e0006629 2018 [PMID: 30080852]
  25. Moysi E, Petrovas C, Koup RA. The role of follicular helper CD4 T cells in the development of HIV-1 specific broadly neutralizing antibody responses Retrovirology 15(1):54 2018 [PMID: 30081906]
  26. Rademaker M, Agnew K, Anagnostou N, Andrews M, Armour K, Baker C, Foley P, Gebauer K, Gupta M, Marshman G, Rubel D, Sullivan J, Wong LC. Psoriasis and infection. A clinical practice narrative The Australasian journal of dermatology 2018 [PMID: 30079566]
  27. Nemes E, Scriba TJ, Hatherill M. Prospects for a vaccine to prevent HIV-related tuberculosis Current opinion in HIV and AIDS 2018 [PMID: 30080682]
  28. Spina FG, Gouvea A, Succi RCM, Calanca F, Weckx LY, Terreri MT, Takano MAS, de Moraes-Pinto MI. Immune response to a Tdap booster in vertically HIV-infected adolescents Vaccine 2018 [PMID: 30087050]
  29. Itell HL, McGuire EP, Muresan P, Cunningham CK, McFarland EJ, Borkowsky W, Permar SR, Fouda GG. Development and application of a multiplex assay for the simultaneous measurement of antibody responses elicited by common childhood vaccines Vaccine 2018 [PMID: 30087048]
  30. Pasin C, Dufour F, Villain L, Zhang H, Thiébaut R. Controlling IL-7 Injections in HIV-Infected Patients Bulletin of mathematical biology 2018 [PMID: 30073567]
  31. Cohen YZ, Lorenzi JCC, Krassnig L, Barton JP, Burke L, Pai J, Lu CL, Mendoza P, Oliveira TY, Sleckman C, Millard K, Butler AL, Dizon JP, Belblidia SA, Witmer-Pack M, Shimeliovich I, Gulick RM, Seaman MS, Jankovic M, Caskey M, Nussenzweig MC. Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117 The Journal of experimental medicine 2018 [PMID: 30072495]
  32. O'Rourke SM, Byrne G, Tatsuno G, Wright M, Yu B, Mesa KA, Doran RC, Alexander D, Berman PW. Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production PloS one 13(8):e0197656 2018 [PMID: 30071025]
  33. Santos VS, Goletti D, Kontogianni K, Adams ER, Molina-Moya B, Dominguez J, Crudu V, Martins-Filho PRS, Ruhwald M, Lawson L, Bimba JS, Garcia-Bastero AL, Petrone L, Kabeer BS, Reither K, Cuevas LE. Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: a systematic review and meta-analysis Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2018 [PMID: 30076971]
  34. Bianchi M, Turner HL, Nogal B, Cottrell CA, Oyen D, Pauthner M, Bastidas R, Nedellec R, McCoy LE, Wilson IA, Burton DR, Ward AB, Hangartner L. Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization Immunity 2018 [PMID: 30097292]
  35. da Silva LT, da Silva WC, de Almeida A, da Silva Reis D, Santillo BT, Rigato PO, da Silva Duarte AJ, Oshiro TM. Characterization of monocyte-derived dendritic cells used in immunotherapy for HIV-1-infected individuals Immunotherapy 10(10):871-885 2018 [PMID: 30073900]
  36. Christensen-Quick A, Chaillon A, Yek C, Zanini F, Jordan P, Ignacio C, Caballero G, Gianella S, Smith D. Influenza Vaccination Can Broadly Activate the HIV Reservoir During Antiretroviral Therapy Journal of acquired immune deficiency syndromes (1999) 2018 [PMID: 30085954]
  37. Anang S, Kaushik N, Hingane S, Kumari A, Gupta J, Asthana S, Shalimar, Nayak B, Ranjith-Kumar CT, Surjit M. Potent inhibition of hepatitis E virus release by a cyclic peptide inhibitor of the interaction between viral open reading frame 3 protein and host tumor susceptibility gene 101 Journal of virology 2018 [PMID: 30068652]
  38. Li Y, Masse-Ranson G, Garcia Z, Bruel T, Kök A, Strick-Marchand H, Jouvion G, Serafini N, Lim AI, Dusseaux M, Hieu T, Bourgade F, Toubert A, Finke D, Schwartz O, Bousso P, Mouquet H, Di Santo JP. A human immune system mouse model with robust lymph node development Nature methods 15(8):623-630 2018 [PMID: 30065364]
  39. Rasmussen DN, Unger HW, Bjerregaard-Andersen M, da Silva Té D, Vieira N, Oliveira I, Hønge BL, Jespersen S, Gomes MA, Aaby P, Wejse C, Sodemann M. Political instability and supply-side barriers undermine the potential for high participation in HIV testing for the prevention of mother-to-child transmission in Guinea-Bissau: A retrospective cross-sectional study PloS one 13(8):e0199819 2018 [PMID: 30067793]
  40. Ortiz AM, Flynn JK, DiNapoli SR, Vujkovic-Cvijin I, Starke CE, Lai SH, Long ME, Sortino O, Vinton CL, Mudd JC, Johnston L, Busman-Sahay K, Belkaid Y, Estes JD, Brenchley JM. Experimental microbial dysbiosis does not promote disease progression in SIV-infected macaques Nature medicine 2018 [PMID: 30061696]
  41. Sagara I, Healy SA, Assadou MH, Gabriel EE, Kone M, Sissoko K, Tembine I, Guindo MA, Doucoure M, Niaré K, Dolo A, Rausch KM, Narum DL, Jones DL, MacDonald NJ, Zhu D, Mohan R, Muratova O, Baber I, Coulibaly MB, Fay MP, Anderson C, Wu Y, Traore SF, Doumbo OK, Duffy PE. Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults The Lancet. Infectious diseases 2018 [PMID: 30061051]
  42. Kwenti TE. Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies Research and reports in tropical medicine 9:123-136 2018 [PMID: 30100779]
  43. Stadtmueller BM, Bridges MD, Dam KM, Lerch MT, Huey-Tubman KE, Hubbell WL, Bjorkman PJ. DEER Spectroscopy Measurements Reveal Multiple Conformations of HIV-1 SOSIP Envelopes that Show Similarities with Envelopes on Native Virions Immunity 2018 [PMID: 30076100]
  44. Duan H, Chen X, Boyington JC, Cheng C, Zhang Y, Jafari AJ, Stephens T, Tsybovsky Y, Kalyuzhniy O, Zhao P, Menis S, Nason MC, Normandin E, Mukhamedova M, DeKosky BJ, Wells L, Schief WR, Tian M, Alt FW, Kwong PD, Mascola JR. Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies Immunity 2018 [PMID: 30076101]
  45. Paulk NK, Pekrun K, Charville GW, Maguire-Nguyen K, Wosczyna MN, Xu J, Zhang Y, Lisowski L, Yoo B, Vilches-Moure JG, Lee GK, Shrager JB, Rando TA, Kay MA. Bioengineered Viral Platform for Intramuscular Passive Vaccine Delivery to Human Skeletal Muscle Molecular therapy. Methods & clinical development 10:144-155 2018 [PMID: 30101152]
  46. Yang L, Sharma SK, Cottrell C, Guenaga J, Tran K, Wilson R, Behrens AJ, Crispin M, de Val N, Wyatt RT. Structure-Guided Redesign Improves NFL HIV Env Trimer Integrity and Identifies an Inter-Protomer Disulfide Permitting Post-Expression Cleavage Frontiers in immunology 9:1631 2018 [PMID: 30065725]
  47. Motaze NV, Nwachukwu C, Humphreys E. Treatment interventions for diarrhoea in HIV-infected and HIV-exposed children: a systematic review The Pan African medical journal 29:208 2018 [PMID: 30100962]
  48. Soumana A, Kamaye M, Ngoumbouté I, Dima H, Daouda B, Guéro T. [Tuberculosis in children: 29 cases in two hospitals of Niamey and at the national tuberculosis center] Le Mali medical 31(4):1-8 2016 [PMID: 30079650]

Marburg virus

  1. Bramble MS, Hoff N, Gilchuk P, Mukadi P, Lu K, Doshi RH, Steffen I, Nicholson BP, Lipson A, Vashist N, Sinai C, Spencer D, Olinger G, Wemakoy EO, Illunga BK, Pettitt J, Logue J, Marchand J, Varughese J, Bennett RS, Jahrling P, Cavet G, Serafini T, Ollmann Saphire E, Vilain E, Muyembe-Tamfum JJ, Hensely LE, Simmons G, Crowe JE Jr, Rimoin AW. Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors The Journal of infectious diseases 2018 [PMID: 30107445]
  2. Miraglia CM. Marburgviruses: An Update Laboratory medicine 2018 [PMID: 30085179]

Mycobacterium tuberculosis (tuberculosis)

  1. Igo RP Jr, Hall NB, Malone LL, Hall JB, Truitt B, Qiu F, Tao L, Mupere E, Schnell A, Hawn TR, Bush WS, Joloba M, Boom WH, Stein CM. Fine-mapping analysis of a chromosome 2 region linked to resistance to Mycobacterium tuberculosis infection in Uganda reveals potential regulatory variants Genes and immunity 2018 [PMID: 30100616]
  2. Mani R, Gupta M, Malik A, Tandon R, Prasad R, Bhatnagar R, Banerjee N. Adjuvant Potential of Poly-α-L-glutamine from Cell Wall of <i>Mycobacterium tuberculosis</i> Infection and immunity 2018 [PMID: 30104212]
  3. Son M, Park YS, Jung MH, Kang JH, Choi UY. Risk factors for latent tuberculosis infection in children in South Korea Postgraduate medicine 2018 [PMID: 30095331]
  4. Suliman S, Luabeya AKK, Geldenhuys H, Tameris M, Hoff ST, Shi Z, Tait D, Kromann I, Ruhwald M, Rutkowski KT, Shepherd B, Hokey D, Ginsberg AM, Hanekom WA, Andersen P, Scriba TJ, Hatherill M. Dose Optimization of H56:IC31 Vaccine for TB Endemic Populations: A Double-Blind, Placebo-Controlled, Dose-Selection Trial American journal of respiratory and critical care medicine 2018 [PMID: 30092143]
  5. Heenan RC, Volkman T, Stokes S, Tosif S, Graham H, Smith A, Tran D, Paxton G. 'I think we've had a health screen': New offshore screening, new refugee health guidelines, new Syrian and Iraqi cohorts: Recommendations, reality, results and review Journal of paediatrics and child health 2018 [PMID: 30094942]
  6. Ranchod H, Ndlandla F, Lemmer Y, Beukes M, Niebuhr J, Al-Dulayymi J, Wemmer S, Fehrsen J, Baird M, Verschoor J. The antigenicity and cholesteroid nature of mycolic acids determined by recombinant chicken antibodies PloS one 13(8):e0200298 2018 [PMID: 30092023]
  7. Jin JW, Tang SQ, Rong MZ, Zhang MQ. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses Acta biomaterialia 2018 [PMID: 30098441]
  8. Khoshnood S, Heidary M, Haeili M, Drancourt M, Darban-Sarokhalil D, Nasiri MJ, Lohrasbi V. Novel vaccine candidates against Mycobacterium tuberculosis International journal of biological macromolecules 2018 [PMID: 30098365]
  9. Kloning T, Nowotny T, Alberer M, Hoelscher M, Hoffmann A, Froeschl G. Morbidity profile and sociodemographic characteristics of unaccompanied refugee minors seen by paediatric practices between October 2014 and February 2016 in Bavaria, Germany BMC public health 18(1):983 2018 [PMID: 30086731]
  10. Maarsingh JD, Haydel SE. Mycobacterium smegmatis PrrAB two-component system influences triacylglycerol accumulation during ammonium stress Microbiology (Reading, England) 2018 [PMID: 30084767]
  11. Walters LC, Harlos K, Brackenridge S, Rozbesky D, Barrett JR, Jain V, Walter TS, O'Callaghan CA, Borrow P, Toebes M, Hansen SG, Sacha J, Abdulhaqq S, Greene JM, Früh K, Marshall E, Picker LJ, Jones EY, McMichael AJ, Gillespie GM. Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding Nature communications 9(1):3137 2018 [PMID: 30087334]
  12. Bull NC, Kaveh DA, Garcia-Pelayo MC, Stylianou E, McShane H, Hogarth PJ. Induction and maintenance of a phenotypically heterogeneous lung tissue-resident CD4<sup>+</sup> T cell population following BCG immunisation Vaccine 2018 [PMID: 30097220]
  13. Nemes E, Scriba TJ, Hatherill M. Prospects for a vaccine to prevent HIV-related tuberculosis Current opinion in HIV and AIDS 2018 [PMID: 30080682]
  14. Mawatwal S, Behura A, Mishra A, Singh R, Dhiman R. Calcimycin induced IL-12 production inhibits intracellular mycobacterial growth by enhancing autophagy Cytokine 111:1-12 2018 [PMID: 30081297]
  15. Santos VS, Goletti D, Kontogianni K, Adams ER, Molina-Moya B, Dominguez J, Crudu V, Martins-Filho PRS, Ruhwald M, Lawson L, Bimba JS, Garcia-Bastero AL, Petrone L, Kabeer BS, Reither K, Cuevas LE. Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: a systematic review and meta-analysis Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2018 [PMID: 30076971]
  16. Ismail NA, Omar SV, Mvusi L, Madhi SA. Prevalence of drug-resistant tuberculosis in South Africa - Authors' reply The Lancet. Infectious diseases 18(8):836-837 2018 [PMID: 30064675]
  17. Schrager LK, Chandrasekaran P, Fritzell BH, Hatherill M, Lambert PH, McShane H, Tornieporth N, Vekemans J. WHO preferred product characteristics for new vaccines against tuberculosis The Lancet. Infectious diseases 18(8):828-829 2018 [PMID: 30064668]
  18. Chihota VN, Niehaus A, Streicher EM, Wang X, Sampson SL, Mason P, Källenius G, Mfinanga SG, Pillay M, Klopper M, Kasongo W, Behr MA, Gey van Pittius NC, van Helden PD, Couvin D, Rastogi N, Warren RM. Geospatial distribution of Mycobacterium tuberculosis genotypes in Africa PloS one 13(8):e0200632 2018 [PMID: 30067763]
  19. Chandrasekaran P, Mave V, Thiruvengadam K, Gupte N, Shivakumar SVBY, Hanna LE, Kulkarni V, Kadam D, Dhanasekaran K, Paradkar M, Thomas B, Kohli R, Dolla C, Bharadwaj R, Sivaramakrishnan GN, Pradhan N, Gupte A, Murali L, Valvi C, Swaminathan S, Gupta A. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting PloS one 13(8):e0199360 2018 [PMID: 30067752]
  20. Thakur A, Andrea A, Mikkelsen H, Woodworth JS, Andersen P, Jungersen G, Aagaard C. Targeting the Mincle and TLR3 receptor using the dual agonist cationic adjuvant formulation 9 (CAF09) induces humoral and polyfunctional memory T cell responses in calves PloS one 13(7):e0201253 2018 [PMID: 30063728]
  21. Filardy AA, Guimarães-Pinto K, Nunes MP, Zukeram K, Fliess L, Pereira L, Oliveira Nascimento D, Conde L, Morrot A. Human Kinetoplastid Protozoan Infections: Where Are We Going Next? Frontiers in immunology 9:1493 2018 [PMID: 30090098]
  22. Radloff J, Heyckendorf J, van der Merwe L, Sanchez Carballo P, Reiling N, Richter E, Lange C, Kalsdorf B. <i>Mycobacterium</i> Growth Inhibition Assay of Human Alveolar Macrophages as a Correlate of Immune Protection Following Mycobacterium bovis Bacille Calmette-Guérin Vaccination Frontiers in immunology 9:1708 2018 [PMID: 30087678]
  23. Epstein DJ, Dunn J, Deresinski S. Infectious Complications of Multiple Sclerosis Therapies: Implications for Screening, Prophylaxis, and Management Open forum infectious diseases 5(8):ofy174 2018 [PMID: 30094293]
  24. Niki M, Yoshiyama T, Miyamoto Y, Okumura M, Niki M, Oinuma KI, Kaneko Y, Matsumoto S, Sasaki Y, Ogata H, Goto H, Kudoh S, Hoshino Y. Longitudinal Evaluation of Humoral Immunity and Bacterial and Clinical Parameters Reveals That Antigen-Specific Antibodies Suppress Inflammatory Responses in Active Tuberculosis Patients Journal of immunology research 2018:4928757 2018 [PMID: 30069487]
  25. Martini M, Paluan F. Tuberculosis in Genoa: the contribution of Edoardo Maragliano (1849-1940) and the Medical School of the University of Genoa Journal of preventive medicine and hygiene 59(2):E172-E175 2018 [PMID: 30083626]
  26. Nemes E, Meermeier EW, Scriba TJ, Walzl G, Malherbe ST, Lewinsohn DM. Diagnostic Challenge of Tuberculosis Heterogeneity Seminars in respiratory and critical care medicine 39(3):286-296 2018 [PMID: 30071544]
  27. Singh AK, Gupta UD. Animal models of tuberculosis: Lesson learnt The Indian journal of medical research 147(5):456-463 2018 [PMID: 30082569]
  28. Li Y, Spiropoulos J, Cooley W, Khara JS, Gladstone CA, Asai M, Bossé JT, Robertson BD, Newton SM, Langford PR. Galleria mellonella - a novel infection model for the Mycobacterium tuberculosis complex Virulence 9(1):1126-1137 2018 [PMID: 30067135]
  29. Soumana A, Kamaye M, Ngoumbouté I, Dima H, Daouda B, Guéro T. [Tuberculosis in children: 29 cases in two hospitals of Niamey and at the national tuberculosis center] Le Mali medical 31(4):1-8 2016 [PMID: 30079650]
  30. Ní Bhuachalla D, Corner LA, More SJ, Gormley E. The role of badgers in the epidemiology of <i>Mycobacterium bovis</i> infection (tuberculosis) in cattle in the United Kingdom and the Republic of Ireland: current perspectives on control strategies Veterinary medicine (Auckland, N.Z.) 6:27-38 2015 [PMID: 30101094]

Nipah virus

  1. Chattu VK, Kumar R, Kumary S, Kajal F, David JK. Nipah virus epidemic in southern India and emphasizing "One Health" approach to ensure global health security Journal of family medicine and primary care 7(2):275-283 2018 [PMID: 30090764]

Plasmodium falciparum (Malaria)

  1. Marin-Mogollon C, van Pul FJA, Miyazaki S, Imai T, Ramesar J, Salman AM, Winkel BMF, Othman AS, Kroeze H, Chevalley-Maurel S, Reyes-Sandoval A, Roestenberg M, Franke-Fayard B, Janse CJ, Khan SM. Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites Malaria journal 17(1):288 2018 [PMID: 30092798]
  2. Jin JW, Tang SQ, Rong MZ, Zhang MQ. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses Acta biomaterialia 2018 [PMID: 30098441]
  3. Phillips B, Van Rompay KKA, Rodriguez-Nieves J, Lorin C, Koutsoukos M, Tomai M, Fox CB, Eudailey J, Dennis M, Alam SM, Hudgens M, Fouda G, Pollara J, Moody A, Shen X, Ferrari G, Permar S, De Paris K. Adjuvant-dependent enhancement of HIV Env-specific antibody responses in infant rhesus macaques Journal of virology 2018 [PMID: 30089691]
  4. Pawliw R, Farrow R, Sekuloski S, Jennings H, Healer J, Phuong T, Sathe P, Pasay C, Evans K, Cowman AF, Schofield L, Chen N, McCarthy J, Trenholme K. A bioreactor system for the manufacture of a genetically modified Plasmodium falciparum blood stage malaria cell bank for use in a clinical trial Malaria journal 17(1):283 2018 [PMID: 30081913]
  5. He L, He P, Luo X, Li M, Yu L, Guo J, Zhan X, Zhu G, Zhao J. The MEP pathway in Babesia orientalis apicoplast, a potential target for anti-babesiosis drug development Parasites & vectors 11(1):452 2018 [PMID: 30081952]
  6. Thái TL, Jun H, Lee J, Kang JM, Lê HG, Lin K, Thant KZ, Sohn WM, Kim TS, Na BK. Genetic diversity of merozoite surface protein-1 C-terminal 42 kDa of Plasmodium falciparum (PfMSP-1<sub>42</sub>) may be greater than previously known in global isolates Parasites & vectors 11(1):455 2018 [PMID: 30081943]
  7. Sarfo BO, Hahn A, Schwarz NG, Jaeger A, Sarpong N, Marks F, Adu-Sarkodie Y, Tamminga T, May J. The usefulness of C-reactive protein in predicting malaria parasitemia in a sub-Saharan African region PloS one 13(8):e0201693 2018 [PMID: 30080904]
  8. Agrawal A, Bisharyan Y, Papoyan A, Bednenko J, Cardarelli J, Yao M, Clark T, Berkmen M, Ke N, Colussi P. Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli Protein expression and purification 2018 [PMID: 30081196]
  9. Delves MJ, Angrisano F, Blagborough AM. Antimalarial Transmission-Blocking Interventions: Past, Present, and Future Trends in parasitology 2018 [PMID: 30082147]
  10. Oakley MS, Verma N, Myers TG, Zheng H, Locke E, Morin MJ, Tripathi AK, Mlambo G, Kumar S. Transcriptome analysis based detection of Plasmodium falciparum development in Anopheles stephensi mosquitoes Scientific reports 8(1):11568 2018 [PMID: 30068910]
  11. Ishino T, Tsuboi T. Progress toward a transmission-blocking vaccine against malaria The Lancet. Infectious diseases 2018 [PMID: 30061052]
  12. Sagara I, Healy SA, Assadou MH, Gabriel EE, Kone M, Sissoko K, Tembine I, Guindo MA, Doucoure M, Niaré K, Dolo A, Rausch KM, Narum DL, Jones DL, MacDonald NJ, Zhu D, Mohan R, Muratova O, Baber I, Coulibaly MB, Fay MP, Anderson C, Wu Y, Traore SF, Doumbo OK, Duffy PE. Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults The Lancet. Infectious diseases 2018 [PMID: 30061051]
  13. Kwenti TE. Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies Research and reports in tropical medicine 9:123-136 2018 [PMID: 30100779]
  14. Bowyer G, Grobbelaar A, Rampling T, Venkatraman N, Morelle D, Ballou RW, Hill AVS, Ewer KJ. CXCR3<sup>+</sup> T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against Malaria Frontiers in immunology 9:1660 2018 [PMID: 30090099]
  15. Othman AS, Franke-Fayard BM, Imai T, van der Gracht ETI, Redeker A, Salman AM, Marin-Mogollon C, Ramesar J, Chevalley-Maurel S, Janse CJ, Arens R, Khan SM. OX40 Stimulation Enhances Protective Immune Responses Induced After Vaccination With Attenuated Malaria Parasites Frontiers in cellular and infection microbiology 8:247 2018 [PMID: 30073152]
  16. Motaze NV, Nwachukwu C, Humphreys E. Treatment interventions for diarrhoea in HIV-infected and HIV-exposed children: a systematic review The Pan African medical journal 29:208 2018 [PMID: 30100962]

Rickettsia prowazekii (Typhus fever)

  1. Ashurst JV, Woodbury B. Salmonella, Typhi 2018 [PMID: 30085544]

Salmonella

  1. Ahn H, Kim J, Kwon S, Kim PH, Kwon HM, Lee E, Lee GS. Triggers of NLRC4 and AIM2 inflammasomes induce porcine IL-1β secretion Veterinary research communications 2018 [PMID: 30097755]
  2. Vijayababu P, Samykannu G, Antonyraj CB, Narayanan S, Basheer Ahamed SI, Perumal P, Piramanayagam S. B-cell and T-cell epitope identification with stability analysis of AI-2 import ATP-binding cassette LsrA from S. typhi -In silico approach Microbial pathogenesis 2018 [PMID: 30098402]
  3. Dicks LMT, Mikkelsen LS, Brandsborg E, Marcotte H. Clostridium difficile, the Difficult "Kloster" Fuelled by Antibiotics Current microbiology 2018 [PMID: 30084095]
  4. Balasubramanian R, Im J, Lee JS, Jeon HJ, Mogeni OD, Kim JH, Rakotozandrindrainy R, Baker S, Marks F. The global burden and epidemiology of invasive non-typhoidal Salmonella infections Human vaccines & immunotherapeutics 2018 [PMID: 30081708]
  5. Ashurst JV, Woodbury B. Salmonella, Typhi 2018 [PMID: 30085544]
  6. Holstege MMC, de Bont-Smolenaars AJG, Santman-Berends IMGA, van der Linde-Witteveen GM, van Schaik G, Velthuis AGJ, Lam TJGM. Factors associated with high antimicrobial use in young calves at Dutch dairy farms: A case-control study Journal of dairy science 2018 [PMID: 30077440]
  7. Kim WK, Moon JY, Cho JS, Park BY, Hur J. Protective efficacy of a canine brucellosis vaccine candidate based on live attenuated Salmonella expressing recombinant Brucella BSCP31, Omp3b and SOD proteins in Beagles The Journal of veterinary medical science 2018 [PMID: 30068897]

Shigella

  1. Ndungo E, Randall A, Hazen TH, Kania DA, Trappl-Kimmons K, Liang X, Barry EM, Kotloff KL, Chakraborty S, Mani S, Rasko DA, Pasetti MF. A Novel <i>Shigella</i> Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge mSphere 3(4) 2018 [PMID: 30068560]

Variola major (Smallpox)

  1. Carius BM, Dodge PM, Randles JD. Smallpox Autoinoculation Via Tattoo in a Soldier Military medicine 2018 [PMID: 30085282]

Vibrio cholerae

  1. Shekar A, Ramlal S, Jeyabalaji JK, Sripathy MH. Intranasal immunization of cocktail/fusion protein containing Tir along with ΔG active fragment of Zot as mucosal adjuvant confers enhanced immunogenicity and reduces E. coli O157:H7 shedding in mice International immunopharmacology 63:211-219 2018 [PMID: 30103196]

Click HERE to see the publications in the last month.